The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review
Journal of Gastroenterology and Hepatology · 2023-02 · 38 (2) · 187-196
DOI: 10.1111/jgh.16042 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 08.11.2022. Verfasst von Bo Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, Ch…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Metabolic Syndrome. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim Metabolic syndrome (MetS) increases the risk of colorectal cancer (CRC), and the impact of MetS on CRC prognosis remains controversial after the diagnosis of CRC has been established. This study aimed to explore the impact of the individual components and synergies of MetS on the prognosis of patients with CRC.
Methods
We searched articles published before August 3, 2022, in four databases, including PubMed, Embase, Cochrane Library, and ScienceDirect. The random‐effects model inverse variance method was used to estimate the summarized effect size.
Results
Patients with CRC with MetS were 1.342 times more likely to experience all‐cause mortality than those without MetS, and the 95% confidence interval (CI) of hazard ratio (HR) was 1.107–1.627 ( P = 0.003). CRC‐specific mortality in patients with CRC with MetS was 2.122 times higher than in those without MetS, and the 95% CI of HR was 1.080–4.173 ( P = 0.029). CRC‐specific mortality exhibited an increasing trend of risk with increased metabolic risk factors. The HR of CRC‐specific mortality for one, two, and three metabolic risk factors was 1.206 (95% CI, 1.034–1.407; P = 0.017), 1.881 (95% CI, 1.253–2.824; P = 0.002), and 2.327 (95% CI, 1.262–4.291; P = 0.007), respectively.
Conclusions
Metabolic syndrome increased all‐cause and CRC‐specific mortality in patients with CRC. As a single component of MetS, diabetes mellitus increased overall mortality in patients with CRC, while obesity increased CRC‐specific mortality in patients with CRC, with a significant difference from non‐MetS. Moreover, the risk of CRC‐specific mortality increased with increasing number of metabolic risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Jia-Ming Qian, Jing-Nan Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lu, B., Qian, J. M., & Li, J. N. (2023). The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology, 38(2), 187-196. https://doi.org/10.1111/jgh.16042
Vancouver
Lu B, Qian JM, Li JN. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology. 2023;38(2):187-196. doi:10.1111/jgh.16042
BibTeX
@article{Lu2023,
author = {Lu, Bo and Qian, Jia-Ming and Li, Jing-Nan},
title = {The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
volume = {38},
number = {2},
pages = {187--196},
doi = {10.1111/jgh.16042}
}
EUVIMED